BriaCell Therapeutics Corp. (BCTX) stock

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ

Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30

$3.51−0.08 (-2.23%)

Close on Nov 12, 2026Market cap $30.65MP/E –Yield –

BriaCell Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

BriaCell Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?